# Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension

Study · id `cardio:ct-nct00994617` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00994617](<https://clinicaltrials.gov/study/NCT00994617>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00994617

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.

## Technical summary

Registry record NCT00994617. Randomized; double masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT00994617, source copy `cardio:ctgov-nct00994617-2013-06-12`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT00994617, source copy `cardio:ctgov-nct00994617-2013-06-12`, retrieved 2026-10-26)
- Primary completion: 2014-12 (anticipated) (ClinicalTrials.gov record NCT00994617, source copy `cardio:ctgov-nct00994617-2013-06-12`, retrieved 2026-10-26)
- Completion: 2014-12 (anticipated) (ClinicalTrials.gov record NCT00994617, source copy `cardio:ctgov-nct00994617-2013-06-12`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT00994617, source copy `cardio:ctgov-nct00994617-2013-06-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00994617-2013-06-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension
- Acronym: Pathway 1
- Condition: Hypertension, Resistant to Conventional Therapy
- Condition: Essential Hypertension
- Intervention (Drug): Losartan and hydrochlorothiazide
- Intervention (Drug): Hydrochlorothiazide switched over with Losartan at 8 weeks
- Lead sponsor: University of Cambridge
- Lead sponsor class: OTHER
- Collaborator: British Heart Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of Cambridge (`cardio:org-university-of-cambridge`)
- Registry lists this organization as a collaborator: British Heart Foundation (`cardio:org-british-heart-foundation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double-Blind Randomized Controlled Trial (`cardio:pubmed-29151036`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b6082b86dc02361e81007a08e0f55463524318fa2037490ba6877b3aaa6e37c9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
